A Public Dialogue to Inform the Use of Wider Genomic Testing When Used as Part of Newborn Screening to Identify Cystic Fibrosis
Cystic fibrosis (CF) has been included within the UK national newborn screening programme since 2007. The approach uses measures of immunoreactive trypsin (IRT) in dried blood spot samples obtained at day 5 of life. Samples which reveal IRT results >99.5th centile go on to be tested for a limited...
Saved in:
Main Authors: | Suzannah Kinsella (Author), Henrietta Hopkins (Author), Lauren Cooper (Author), James R. Bonham (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2022-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Parents' and childrens' views of wider genomic testing when used as part of newborn screening to identify cystic fibrosis
by: Jane Chudleigh, et al.
Published: (2024) -
International Perspectives of Extended Genetic Sequencing When Used as Part of Newborn Screening to Identify Cystic Fibrosis
by: Corinna C. A. Clark, et al.
Published: (2024) -
Newborn Screening for Cystic Fibrosis
Published: (2020) -
Human difference in the genomic era: Facilitating a socially responsible dialogue
by: Nowinski Juleigh, et al.
Published: (2010) -
Cystic fibrosis: when neonatal screening is unsatisfactory for early diagnosis
by: Carolina Godoy, et al.
Published: (2024)